These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36247255)

  • 1. LncRNA FGD5-AS1 reduces cardiomyocyte apoptosis and inflammation by modulating Akt and miR-223-3p expression.
    Zhao Y; Wang C; Cui T; Wang Q; Xu Y; Miao C; Liu S
    Am J Transl Res; 2022; 14(9):6175-6186. PubMed ID: 36247255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
    Li B; Yu X; Pang F
    Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes.
    Fang XL; Shi SG
    Hum Exp Toxicol; 2022; 41():9603271221138969. PubMed ID: 36445031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.
    Yang Y; Sun Z; Liu F; Bai Y; Wu F
    Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
    Yang Y; Dong MH; Hu HM; Min QH; Xiao L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.
    Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB
    Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGD5-AS1 facilitates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting the miR-506-3p/BMP7 axis.
    Li J; Wu X; Shi Y; Zhao H
    J Orthop Surg Res; 2021 Nov; 16(1):665. PubMed ID: 34772438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
    Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
    Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
    Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W
    Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lncrna FGD5-AS1 Aggravates Myocardial Ischemia-Reperfusion Injury by Sponging Mir-129-5p.
    Wei P; Dong Z; Lou M
    Iran J Public Health; 2022 Oct; 51(10):2281-2288. PubMed ID: 36415802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
    Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
    Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
    Su D; Ji Z; Xue P; Guo S; Jia Q; Sun H
    Cancer Manag Res; 2020; 12():6317-6329. PubMed ID: 32848452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
    Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
    Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Long Noncoding RNA FGD5-AS1 Ameliorates Myocardial Ischemia/Reperfusion Injury via MicroRNA-106a-5p and MicroRNA-106b-5p.
    Hao L; Wang J; Bi SJ; Cheng C
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e45-e54. PubMed ID: 34173804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-coding RNA FGD5-AS1 Regulates Cancer Cell Proliferation and Chemoresistance in Gastric Cancer Through miR-153-3p/CITED2 Axis.
    Gao Y; Xie M; Guo Y; Yang Q; Hu S; Li Z
    Front Genet; 2020; 11():715. PubMed ID: 32849774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis.
    Liu W; Lin W; Yu L
    Bioengineered; 2022 Jan; 13(1):1424-1435. PubMed ID: 34978261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.
    Shuang O; Zhou J; Cai Z; Liao L; Wang Y; Wang W; Xu M
    J Orthop Surg Res; 2022 Jun; 17(1):332. PubMed ID: 35761386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
    Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
    Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway.
    Chen H; Lan Z; Li Q; Li Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2098-2106. PubMed ID: 31144533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Long Non-Coding RNA AFAP1-AS1 Promoted Viability and Suppressed Death of Cardiomyocytes in Response to I/R In Vitro and In Vivo.
    Chen Z; Wang X; Hou X; Ding F; Yi K; Zhang P; You T
    J Cardiovasc Transl Res; 2020 Dec; 13(6):996-1007. PubMed ID: 32406007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.